Effect of vitamin D supplementation as an adjuvant therapy in Chinese patients with coronary artery disease: A Randomized Placebo-Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003958

Enrollment

Unknown

Registered

2013-12-08

Start date

2013-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

vitamin D supplementation group:vitamin D supplementation

Control group:placebo tablets

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were coronary artery disease and residence in Beijing.

Exclusion criteria

Exclusion criteria: The exclusion criteria were as follows: patients with chronic renal failure, chronic liver disease, obstructive sleep apnea, chronic obstructive pulmonary disease, systemic infection, inflammatory diseases, trauma, bone disorders, and/or thyroid disorders. Patients who underwent coronary stent implantation before were excluded from the study. Patients were also excluded if they were taking cholecalciferol or vitamin D3 tablets, either of which can have an effect on the vitamin D level.

Design outcomes

Primary

Measure	Time frame
Coronary angiography (SYNTAX score);	—

Secondary

Measure	Time frame
Hs-CRP;parathyroid hormone;renin-angiotensin system;	—

Countries

China

Contacts

Public ContactYang Shi

PLA General Hospital at Beijing

ggyyong@sina.com+86 10-66876221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026